HeartWare aims to overtake Thoratec with WorldHeart buy
This article was originally published in Clinica
Executive Summary
Mechanical heart developer HeartWare International has agreed to buy struggling rival firm WorldHeart for $8m to expand its technology offering as it vies to become the number one in the left ventricular assist device (LVAD) market, currently led by Thoratec.